Once implemented, wipe analysis should be conducted regularly, as the greatest benefit is derived from trending data over time; this should not be a one and done activity. Because change is a constant in the cleanroom—from the introduction of new staff to new products—frequent sampling is necessary to reflect accurate data. Consider expanding the use of wipe sampling beyond the pharmacy to benefit administration sites as well. Given that wipe sampling is likely to identify HD contamination, it is important to track the data over time to identify any developing trends.
While leveraging wipe analysis to identify HD residue is increasingly common, 55% of facilities have yet to implement this practice.
Underscoring the value of clear data, an impressive 68% of facilities currently without wipe analysis are planning to adopt it.
Wipe analysis is typically used in the cleanroom, particularly in the PECs and on the HD cleanroom floor, but it is utilized less frequently in HD storage areas and on nursing units where HDs are administered.
Most facilities planning to adopt wipe analysis have established an aggressive timeline, expecting to implement this technology within the next year.
For facilities looking to adopt this technology, ChemoGlo and BD lead the deep market of vendors under consideration.
Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.